Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 2 |
Apple
AAPL
|
+$949M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$788M |
| 4 |
Microsoft
MSFT
|
+$654M |
| 5 |
Broadcom
AVGO
|
+$568M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.26B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$702M |
| 3 |
Tesla
TSLA
|
+$694M |
| 4 |
Micron Technology
MU
|
+$601M |
| 5 |
Strategy Inc
MSTR
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.3% |
| 2 | Technology | 1.97% |
| 3 | Financials | 0.89% |
| 4 | Consumer Discretionary | 0.83% |
| 5 | Healthcare | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11701
Optical Cable Corp
OCC
$122M
| $47K | ﹤0.01% |
+13,024
| New | +$32.2K |
|
11702
PUT
Babcock & Wilcox
BW
$1.14B
| $46.9K | ﹤0.01% |
28,600
-28,900
| -50% | -$61.1K |
|
11703
Xilio Therapeutics
XLO
$59.3M
| $46.9K | ﹤0.01% |
+3,507
| New | +$48.2K |
|
|
RAPT
11704
DELISTED
RAPT Therapeutics
RAPT
| $46.7K | ﹤0.01% |
3,692
+2,417
| +190% | +$30.7K |
|
11705
TOMI Environmental Solutions
TOMZ
$14.4M
| $46.7K | ﹤0.01% |
+14,816
| New | +$35.4K |
|
11706
New Concept Energy
GBR
$3.86M
| $46.6K | ﹤0.01% |
+40,161
| New | +$47.6K |
|
11707
Lulu's Fashion Lounge
LVLU
$37.8M
| $46.3K | ﹤0.01% |
2,731
+1,823
| +201% | +$37.2K |
|
11708
SOPHiA GENETICS
SOPH
$759M
| $46.3K | ﹤0.01% |
+14,835
| New | +$50.5K |
|
11709
Skye Bioscience
SKYE
$8.63M
| $46.3K | ﹤0.01% |
2,044
+132
| +7% | +$4.41K |
|
11710
PUT
Relay Therapeutics
RLAY
$4.26B
| $46.1K | ﹤0.01% |
11,200
-11,200
| -50% | -$60.9K |
|
|
ICAD
11711
PUT
DELISTED
iCAD Inc
ICAD
| $46.1K | ﹤0.01% |
25,200
+10,900
| +76% | +$19.3K |
|
11712
PUT
Caribou Biosciences
CRBU
$178M
| $46.1K | ﹤0.01% |
+29,000
| New | +$58.3K |
|
11713
CALL
Stem
STEM
$54.9M
| $45.8K | ﹤0.01% |
3,820
-3,980
| -51% | -$34.3K |
|
|
PLG
11714
Platinum Group Metals
PLG
$198M
| $45.8K | ﹤0.01% |
35,747
-6,822
| -16% | -$11K |
|
11715
Key Tronic
KTCC
$41.8M
| $45.7K | ﹤0.01% |
10,959
+64
| +0.6% | +$347 |
|
|
NEWP
11716
New Pacific Metals
NEWP
$1.37B
| $45.7K | ﹤0.01% |
38,703
-569
| -1% | -$887 |
|
11717
CALL
IHS Holding
IHS
$2.82B
| $45.6K | ﹤0.01% |
15,600
-15,000
| -49% | -$45.5K |
|
|
PRT
11718
PermRock Royalty Trust Unit
PRT
$27.1M
| $45.5K | ﹤0.01% |
+12,926
| New | +$49.8K |
|
11719
Santander
BSBR
$42.9B
| $45.2K | ﹤0.01% |
11,570
-4,292
| -27% | -$19.6K |
|
11720
Apyx Medical
APYX
$126M
| $45K | ﹤0.01% |
28,450
+15,380
| +118% | +$21.5K |
|
11721
PUT
Zentalis Pharmaceuticals
ZNTL
$367M
| $44.8K | ﹤0.01% |
14,800
-18,200
| -55% | -$59.6K |
|
11722
CALL
PDS Biotechnology
PDSB
$12.2M
| $44.8K | ﹤0.01% |
+27,500
| New | +$72.8K |
|
|
MRSN
11723
CALL
DELISTED
Mersana Therapeutics
MRSN
| $44.8K | ﹤0.01% |
1,252
-248
| -17% | -$12.8K |
|
|
NVX
11724
NOVONIX
NVX
$901M
| $44.7K | ﹤0.01% |
+2,486
| New | +$48.2K |
|
|
SBDS
11725
DELISTED
Solo Brands Inc
SBDS
| $44.3K | ﹤0.01% |
972
-18
| -2% | -$892 |
|
Similar funds
Jeff Yass's Q4 2024 Portfolio in Review
As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q4 2024 filing shows 1,862 new, 5,386 increased, 4,790 reduced and 1,590 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 94% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
- Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
- Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
- Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
- Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.